Page 49 - Marijuana Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The bill would also allow medical marijuana cardholders to grow up to five marijuana plants at home.

“The stay previously entered by this court is hereby vacated.” As many are well-aware, the cannabis industry has been plagued by litigation, and New Jersey’s recent experience is no different. Indeed, New Jersey has taken great strides to expand its medical marketplace, with the patient population recently eclipsing 100,000 total patients. Moreover, the New Jersey Department of Health, Medical Marijuana Program (“DOH”) was on pace towards expanding access and production to meet this patient demand, until several litigants preliminarily disqualified from the 2019 Request for Applicat...

Move will nearly double patient options; state auditor in favor of legalizing marijuana Looking to boost availability of medical marijuana to an increasing patient population, the state recently awarded three contracts to companies that expect to open a total of five new dispensaries. FILE IMAGE Chris Flood February 16, 2021 State Auditor Kathy McGuiness recently released a report in favor of legalizing marijuana in Delaware so the state can take advantage of an estimated $43 million in potential revenue. SUBMITTED PHOTO Attachments By this time next year, medical marijuana patients...

NORML Adult use marijuana sales could begin “as soon as late January,” according to Arizona’s Department of Health Services (DHS). “We are excited to launch the Adult-Use of Marijuana Program and are expecting a smooth Go-Live,” the DHS stated in an email to dispensaries last week. State regulators have already begun swiftly reviewing marijuana business licenses for existing medical marijuana dispensaries to start selling marijuana to all adults 21 and older. Applications became available to these businesses on January 19. DHS is ahead of schedule, as Proposition 207, the ballot mea...

With legal weed coming to New Jersey, U.S. must open doors for cannabis research Monday, 11 January 2021 There’s an ancient botanical that millions of Americans take for epilepsy, cancer pain, Parkinson’s disease, post-traumatic stress disorder, multiple sclerosis and other serious and debilitating conditions. The drug is cannabis. But American researchers who want to study cannabis are thwarted at every turn. Federal law still classifies cannabis as a Schedule 1 drug, a list that includes highly dangerous and addictive drugs such as heroin. The government says cannabis has...